Product Launching in the Era of COVID-19 - Diagnosing Health Care Podcast

This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing COVID-19 pandemic. The episode offers holistic perspectives from across Epstein Becker Green’s offices and features Members of the Firm Julie Lampley and Lauren Sullivan, Strategic Advisor for EBG Advisors Machelle Dunavant Shields, and host Jessika Tuazon.

Here’s a preview of what See more +

This Diagnosing Health Care episode looks at the adjustments to business operations and compliance programs that pharmaceutical and medical device companies need to consider as they launch new products during the ongoing COVID-19 pandemic. The episode offers holistic perspectives from across Epstein Becker Green’s offices and features Members of the Firm Julie Lampley and Lauren Sullivan, Strategic Advisor for EBG Advisors Machelle Dunavant Shields, and host Jessika Tuazon.

Here’s a preview of what you’ll hear:

“We now see manufacturers looking for more flexibility, ways to be more nimble, and ways to terminate their obligations and liabilities quickly and without cost or penalty.” – Julie Lampley, Member of the Firm

“We just need to step back and look at our guardrails that we currently have in place around our compliance programs, and then make sure that we expand any guardrails or information that should be captured during COVID-19 under the new circumstances.” – Machelle Dunavant Shields, Strategic Advisor

“By ensuring open lines of communication compliance organizations can identify where commercial colleagues are having challenges and collaborate to create a workable solution.” – Lauren Sullivan, Member of the Firm

“In light of unprecedented operational challenges that COVID-19 continues to present, drug and medical device companies should review force majeure provisions to better understand the breadth and scope of the provision, and any strategic advantages the language may pose.” – Jessika Tuazon, Associate

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Listen to the series: http://www.DiagnosingHealthCare.com See less -

Embed
Copy

Other MultiMedia by Epstein Becker & Green

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Epstein Becker & Green | Attorney Advertising

Written by:

Epstein Becker & Green
Contact
more
less

Epstein Becker & Green on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.